Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06630637Not ApplicableCompleted

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Role: lead

NCT06647030Not ApplicableNot Yet Recruiting

Personalized NFTs as a Trial Participation Incentive

Role: lead

NCT06240897Not ApplicableNot Yet Recruiting

CURATE.Dtx as a Diagnostic and Management Tool for Delirium

Role: lead

NCT04506697Not ApplicableUnknown

Remote Monitoring of Uroflowmetry

Role: collaborator

All 4 trials loaded